Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has announced two measures to inform the public about the status of manufacturers’ commitments to carry out further clinical studies following the FDA’s approval of certain drugs and biological products.

Status of postmarketing studies to be posted